Workit Health is a technology company.
Workit Health has raised $102.0M across 2 funding rounds.
Key people at Workit Health.
Workit Health has raised $102.0M in total across 2 funding rounds.
# Workit Health: High-Level Overview
Workit Health is a digital health platform, not a traditional technology company, that delivers virtual addiction treatment through telemedicine.[1][6] Founded in 2015 by Robin McIntosh and Lisa McLaughlin—two women in long-term recovery from addiction—Workit Health has served over 35,000 members by providing medication-assisted treatment (MAT) for opioid use disorder (OUD) and alcohol addiction, alongside treatment for co-occurring conditions like anxiety and depression.[1][6]
The company solves a critical access problem in American addiction care: most people lack convenient, judgment-free treatment options. Workit Health addresses this by offering private, science-backed care accessible entirely online, requiring only an internet connection.[4] The platform combines FDA-approved medications (Suboxone and naltrexone) with behavioral health support from clinicians who specialize in addiction medicine. With a 4.7-star app rating and 3,000+ reviews, Workit Health demonstrates strong product-market fit, particularly among rural populations (20% of members) and treatment-naive patients (75% were new to OUD treatment).[6]
Workit Health emerged from firsthand experience with America's "broken treatment system."[1] Robin McIntosh and Lisa McLaughlin, both in recovery themselves, recognized that traditional in-person rehab models created barriers—stigma, inconvenience, geographic isolation, and cost. Rather than accept these limitations, they built a better alternative in 2015, pioneering virtual addiction care when telemedicine was still nascent in this space.[1]
The company gained early validation through clinical research and strategic partnerships. Workit Health received a Small Business Innovation and Research (SBIR) contract from the National Institute on Drug Abuse (NIDA), the federal government's lead agency on drug use research, to develop telehealth innovations in interoperability and data-driven care.[1] Lux Capital invested in 2016, recognizing the company's potential to scale evidence-based addiction treatment.[2] By 2025, Workit Health has grown to serve 35,000+ members and completed the first study assessing telemedicine treatment for OUD among rural Americans post-COVID, demonstrating the effectiveness of its care model.[1]
Workit Health operates at the intersection of three powerful trends: digital health expansion, addiction crisis urgency, and mental health destigmatization. The opioid epidemic has created sustained demand for scalable treatment solutions, while telemedicine adoption—accelerated by COVID-19—has normalized remote clinical care. Workit Health's success demonstrates that virtual-first models can deliver superior outcomes in addiction treatment, challenging the assumption that in-person rehab is the gold standard.
The company also influences policy and clinical practice. By actively advocating for legislation preserving 100% virtual access to addiction treatment and publishing research demonstrating telemedicine efficacy, Workit Health shapes how payers, regulators, and clinicians think about addiction care delivery.[1] Its partnerships with state health agencies (like OhMHAS in Ohio) show how digital platforms can integrate into broader healthcare systems.
Workit Health is positioned to become the dominant virtual-first addiction treatment platform in America. With 35,000+ members, clinical validation, government research partnerships, and a mission-driven team, the company has built defensible competitive advantages in a market that will only grow as the addiction crisis persists and telemedicine becomes standard.
The next phase likely involves geographic expansion, payer integration, and clinical breadth—treating more co-occurring conditions and reaching underserved populations. As mental health and addiction care converge, Workit Health's integrated approach to depression, anxiety, and substance use positions it well to capture this expanding market.
What makes Workit Health remarkable is that it proves a counterintuitive truth: the most effective addiction treatment platform in America was built not by Silicon Valley technologists, but by two women who lived the problem they solved. That authenticity, combined with clinical rigor and technology, is a rare combination—and likely the reason it's winning.
Key people at Workit Health.
Workit Health has raised $102.0M in total across 2 funding rounds.
Workit Health's investors include FirstMark Capital, Insight Partners, Schematic Ventures.
Workit Health has raised $102.0M across 2 funding rounds. Most recently, it raised $90.0M Series C in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2021 | $90.0M Series C | FirstMark Capital, Insight Partners, Schematic Ventures | |
| Dec 1, 2020 | $12.0M Series B | FirstMark Capital, Schematic Ventures |
